214 funding opportunities are listed in this category
2010 Thomas E. Heftler Migraine Research Award
The American Headache Society® (AHS) and the Migraine Research Foundation (MRF) announce the 2010 Thomas E. Heftler Migraine Research Award. The $10,000 award will recognize the most innovative research proposal in migraine by a neurology resident or headache medicine fellow in an accredited U.S. program. Both clinical and basic science proposals will be considered. Reviewers will look for innovation, impact, and importance to the field of migraine research.The Migraine Research Foundation created and funded the award in memory of Mr. Heftler who was a founding member of the Board of Directors of the Migraine Research Foundation until his untimely death in June 2007. The Migraine Research Foundation is the only organization whose sole purpose is to raise funds for innovative scientific research to further the understanding of the causes and mechanisms of migraine, to develop improvements in treatment, and to find the cure.The American Headache Society® is a professional organization comprised of physicians and other health care professionals dedicated to improving the care and lives of headache sufferers.The criteria are: (1) the quality of the research proposal; (2) the potential for the research to contribute to the advancement of the field of headache medicine; and (3) the quality of the research environment. Awardees must submit a progress report after 6 months of work, an abstract to the 2012 AHS Annual Scientific Meeting to be reviewed for presentation, and a manuscript based on this work to the journal Headache. Headache has the first right of refusal for the manuscript.To be considered for this award, the completed application form and all supporting documents must be received by the AHS Executive Offices no later than 5:00pm EST on March 25, 2010. * Proposals due March 25, 2010 * Winner announced April 15, 2010 * Award research to commence July 1, 2010Please contact the American Headache Society® if you have any questions.American Headache Society®19 Mantua Rd.Mount Royal, NJ 08061Phone: 856-423-0043Fax: 856-423-0082ahshq@talley.com
Barth Syndrome Foundation 2010 International Scientific, Medical & Family Conference Travel Stipends
Poster SessionCall for Poster AbstractsThe Barth Syndrome Foundation 2010 Scientific and Medical Conference Organizing Committee (COC) invites the submission of abstracts for poster presentations related to the scientific and/or clinical aspects of Barth syndrome. The deadline for abstract submission is April 15, 2010. All submitted abstracts will be peer-reviewed by the COC. Once accepted, the submitting author will be expected to present his/her corresponding poster at a specific time during the Conference.All Conference registrants are encouraged to submit abstract(s)/poster(s) of their work. Relevant posters presented within the last two years at other scientific/medical conferences may also be invited to be displayed by contacting the COC with the details.Travel stipends (up to $800) will be available based on need as well as quality of the poster. Completion of an additional form is required to apply for this funding, and we particularly encourage young investigators (including doctoral and post-doctoral attendees) to apply for this feature of the Conference.
Linda StundisExecutive Director675 VFW Parkway #372Chestnut Hill, MA 02467Telephone: (617) 469-6769Facsimile: (617) 849-5695E-mail: Lstundis[at]barthsyndrome.org
International Rett Syndrome Foundation HeART Award (Help Accelerate Rett Therapeutics)
Goal: To provide seed funding for early stage drug discovery and development efforts.Funding: The program provides funding in amounts ranging from $25,000-$50,000 for one year with a high likelihood of follow-on funding for successful programs.HeART Award Timeline
Cycle 1 LOIS due: March 26, 2010Applications due: April 26, 2010
Cycle 2
LOIs due: August 16, 2010Applications due: September 30, 2010
International Rett Syndrome Foundation 4600 Devitt DriveCincinnati OH 45246Telephone: 1-800-818-7388Fax: 1-513-874-2520
2010 Mantle Cell Lymphoma Correlative Clinical Studies Grant
* $100K per year for 2 years: The Lymphoma Research Foundation (LRF) Mantle Cell Lymphoma Consortium seeks proposals for correlative clinical studies in mantle cell lymphoma. Applications to this initiative must be an adjunct to a major MCL research project and work in the clinical setting or with primary MCL patient samples. Innovative research by definition may uncover new questions and new areas requiring investigation. Basic funding often does not allow for additional, correlative studies to explore these areas. The intention of the current request for proposals is to fund such adjunct studies to complement and synergize with ongoing MCL trials within the NCI Cancer Cooperative Groups and/or the LRF-funded clinical projects. The applications should clearly focus on MCL and have a high degree of relevance to research questions pertinent to MCL.
RESEARCH OBJECTIVES:To be considered for funding, an adjunct study should be:1. Associated with an ongoing, clinical research project focused specifically on mantle cell lymphoma and funded by LRF or the NCI.2. Intended to test a new hypothesis based on preliminary findings in the major study.3. Capable of furthering the understanding of mantle cell lymphoma and/or its diagnosis and treatment.Examples of eligible projects include, but are not limited to:--Molecular and/or genetic profiling of patient-derived samples--Identification of biomarkers--Immunological studies• Establishment of tissue arrays and other archival resources
Applications to this initiative must work in the clinical setting or with primary MCL patient samples.
ELIGIBILITY:
You may submit an application if your institution is a:--Non-profit organization--Public or private institution such as a university, college, hospital and/or laboratory
--Domestic or foreign institutions/organizations are eligible
For-profit entities are not eligible to apply for LRF funds, however, should a for-profit institution have a relevant therapeutic or research project, they should contact LRF management to discuss possible public-private partnerships.
Any individual with the skills, knowledge and resources necessary to carry out the proposed research is invited to work with their (eligible) institution to develop an application for support. o Applications are due on August 15, 2010. Applications will be peer-reviewed, and applicants will be notified of results by November 2010.All applications must be submitted electronically. LRF allows up to 25 percent overhead. Smaller overhead amounts are preferred. To apply for these grant opportunities, please go to https://proposalcentral.altum.comFor more information, please call: (800) 235-6848
2010 Mantle Cell Lymphoma Project Planning Grant
$25K for up to 2 years: The Lymphoma Research Foundation's Mantle Cell Lymphoma Consortium is seeking applications for project planning grants geared toward obtaining larger-scale research support from NIH/NCI (or another major funder). The purpose of these grants is to provide funds for MCL Consortium members and other MCL researchers to develop larger, longer-term proposals that are likely to become successfully funded from other sources, including Program Project Grants such as the POI. Multi-invenstigator, multi-site and/or mulit-disciplinary proposals are particularly encouraged.
ELIGIBILITY:All principal investigators holding an academic faculty appointment, at non-profit organizations, or public or private institutions such as universities, colleges, hospitals, and laboratories, may apply for funding. * Applications are due on May 15, 2010. Applications will be peer-reviewed, and applicants will be notified of results by Summer 2010.
Lymphoma Research Foundation115 Broadway, 13th FloorNew York, NY 10006Phone: (212) 349-2910, (800) 235-6848Fax: (212) 349-2886
American Society of Health-System Pharmacists Research and Education Foundation Student Research Award
The Student Research Award is presented annually to a pharmacy student for a published or an unpublished paper or report of a completed research project related to pharmacy practice in a hospitals and health systems. Description of Award The Student Research Award consists of a $1,500 honorarium, a $1,000 expense allowance to attend the ASHP Midyear Clinical Meeting, and a plaque. Eligibility Article The research should be completed and the paper prepared before June 1 of the year preceding the ASHP Midyear Clinical Meeting at which the Award is to be presented. The student should be the primary author of the nominated paper. The text should reveal (or it should be obvious) that it was derived from, or is relevant to, pharmacy practice in hospitals and health systems or should reflect a philosophy applicable to pharmacy practice in those settings. The paper or report should be in publishable format (see “Procedures for submission of manuscripts to journals published by the American Society of Health-System Pharmacists” in the January issue of the American Journal of Health-System Pharmacy for an example of appropriate format). Author At the time of preparation of the paper or report, the author shall have been a full-time student enrolled in an entry-level degree program in an ACPE-accredited college of pharmacy. The nomination should be accompanied by a letter from a faculty member certifying that the nominated paper is primarily the student's work. Selection Process A selection panel will select the highest quality paper that is most pertinent to pharmacy practice in hospitals and health systems. Selection Criteria The following criteria and point values will be used: • Originality - 20 points • Significance - 15 points • Research Methodology - 25 points • Data Analysis - 25 points • Validity of Conclusions - 15 points • Total 100 points
Sponsored by the American Society of Health-System Pharmacists Research and Education Foundation Application Deadline: June 1, 2010 The ASHP Foundation Literature Awards program annually recognizes important contributions to the literature of pharmacy practice in hospitals and health systems. Administered by the ASHP Foundation since 1971, the program is based on the concept that recognition through awards stimulates research and innovation and fosters improvement in the quality of the professional literature. American Society of Health-System Pharmacists Research and Education Foundation 7272 Wisconsin Avenue Bethesda, MD 20814 (301) 664-8612 (301) 634-5712 (fax) foundation@ashp.org www.ashpfoundation.org
Pharmacy Practice Research Award
The Pharmacy Practice Research Award is for an outstanding contribution to the biomedical literature that is relevant to pharmacy practice in hospitals and health systems. The award will be given annually to the author(s) of an important contribution of research relevant to health-system pharmacy practice published during the calendar year preceding the ASHP Midyear Clinical Meeting at which the Award is presented. This award is not intended to recognize research in drug therapy. Description of Award This award consists of a $4,000 honorarium, a $1,000 expense allowance to attend the ASHP Midyear Clinical Meeting for the award presentation, and a plaque. Eligibility Article For this award, research refers to formalized testing using the scientific approach, and includes survey research, modeling, comparative studies, meta-analysis, and other types of research publications that are not research in drug therapy. Contributions to the biomedical literature eligible for the award may include published materials appearing in the primary literature (electronic or print) that are widely available. The work should reveal (or it should be obvious) that the problem studied was derived from or is applicable to pharmacy practice in hospitals and health systems. Author At the time of the completion of the research, the nominated author (or, in the case of multiple authorship, at least one of the authors who was a significant contributor to the research) shall have been a pharmacist. Selection Process A selection panel will review submitted publications and select the highest quality paper that is most pertinent to pharmacy practice in hospitals and health systems. Click on the link below for the names of selection panel members: Selection Criteria The following criteria and point values will be used: • Originality - 20 points • Significance to Hospital or Health System Practice - 15 points • Research Methodology - 25 points • Data Analysis - 25 points • Validity of Conclusions - 15 points • Total 100 points
Drug Therapy Research Award
The Drug Therapy Research Award recognizes an outstanding contribution to the biomedical literature of research involving drug efficacy and safety in humans. The award will be given annually to the author(s) of an important research article primarily concerning therapeutic efficacy and drug safety in humans published during the calendar year preceding the ASHP Midyear Clinical Meeting at which the award is presented. Examples of this research include prospective studies that evaluate clinical effects, pharmacodynamics or pharmacokinetics of drug therapy. This award is not intended to recognize research in pharmacy practice or in topics other than drug effects in humans. Description of Award This award consists of a $4,000 honorarium, a $1,000 expense allowance to attend the ASHP Midyear Clinical Meeting for the award presentation, and a plaque. Eligibility Author At the time of the completion of the research, the author (or, in the case of multiple authorship, at least one of the authors who was a significant contributor to the research) shall have been a pharmacist. Article For this award, research refers to formalized testing using the scientific approach and observing the clinical effects of drugs in humans. Contributions to the pharmaceutical literature eligible for the award may include published materials appearing in the primary literature (electronic or print) that are widely available. The work should reveal (or it should be obvious) that the problem studied was derived from or is applicable to drug therapy. Selection Process A selection panel will review submitted publications and select the highest quality article that is most pertinent to drug therapy in hospitals and health systems. Click on the link below for the names of selection panel members: Selection Criteria The following criteria and point values will be used: • Originality - 20 points • Significance - 15 points • Research Methodology - 25 points • Data Analysis - 25 points • Validity of Conclusions - 15 points • Total 100 points
1234567891011...22next
